FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

384929007: Cosyntropin 50mcg/mannitol 10mg injection solution vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1459107012 Cosyntropin 50mcg/mannitol 10mg injection solution vial (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1479209017 Cosyntropin 50mcg/mannitol 10mg injection solution vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3832751000005113 cosyntropin 50 µg/mannitol 10 mg injektionsvæske, opløsning, hætteglas da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
    4727431000005114 cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas Is a cosyntropinpræparat false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracosactide false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticotropin false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas Has manufactured dose form injektionsvæske false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pituitary hormone false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Mannitol (substance) false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas Has manufactured dose form Solution for injection false Inferred relationship Some
    cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas Is a Product containing tetracosactide (medicinal product) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    Back to Start